See how we’ve helped MedTech innovators navigate the path from concept to successful commercialization
Explore how we’ve helped leading MedTech companies achieve their commercialization goals.
Neurology
Novel neurostimulation device needed breakthrough designation and de novo pathway navigation.
Comprehensive regulatory strategy including breakthrough application and clinical trial design.
Cardiology
Novel neurostimulation device needed breakthrough designation and de novo pathway navigation.
Comprehensive regulatory strategy including breakthrough application and clinical trial design.
Diagnostics
Novel neurostimulation device needed breakthrough designation and de novo pathway navigation.
Comprehensive regulatory strategy including breakthrough application and clinical trial design.
Orthopedics
Novel neurostimulation device needed breakthrough designation and de novo pathway navigation.
Comprehensive regulatory strategy including breakthrough application and clinical trial design.
“UnifiMed’s regulatory expertise was instrumental in achieving our FDA clearance ahead of schedule. Their strategic guidance saved us months and millions in development costs.”
“UnifiMed’s regulatory expertise was instrumental in achieving our FDA clearance ahead of schedule. Their strategic guidance saved us months and millions in development costs.”
“UnifiMed’s regulatory expertise was instrumental in achieving our FDA clearance ahead of schedule. Their strategic guidance saved us months and millions in development costs.”
Let’s discuss how UnifiMed can help you achieve your MedTech commercialization goals
